All In MedTech

Device Trial Radar · NCT06368466

A Study to Evaluate Diagnostic Sensitivity and Specificity of iStatis HBsAg Test at the Point-Of-Care Sites

A Prospective Cross-Sectional Study to Evaluate Diagnostic Sensitivity and Specificity of iStatis HBsAg Test at the Point-Of-Care Sites

Last checked: Nov 19, 2026Latest source record: Feb 21, 2025 (this record)Source: ClinicalTrials.govMethods & limitations

Completed

Status

Completed

Enrollment

175

Actual

Start

Apr 30, 2024

Primary completion

Jul 5, 2024

Study completion Dec 19, 2024

Sponsor

Lead sponsor
bioLytical LaboratoriesNot on our public-company list
Sponsor type
Industry
Collaborators
St Vincent's Hospital Melbourne
First posted
Apr 16, 2024

More device trials from this sponsor

Design

Study type
Interventional
Phase
Not applicable (typical for device studies)
Allocation
Non randomized
Model
Single group
Masking
Double (participant, care provider)
Primary purpose
Screening
FDA-regulated device
No
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

A prospective cross-sectional study in which surgically non-invasive sample-taking is done only for the purpose of the study. Capillary (fingerstick) whole blood and EDTA venipuncture whole blood are collected by a healthcare professional. The collected samples of capillary and EDTA whole blood are tested on iStatis and EDTA whole blood sample will be processed to obtain serum and plasma samples to be tested on the iStatis. An aliquot of the collected serum sample will be shipped to the central laboratory for confirmatory testing. The results from iStatis HBsAg Test results will not be used for patient management decisions.

Conditions

  • Hepatitis B
  • Hepatitis B Infection

Interventions

  • iStatis HBsAg TestDevice

    capillary (fingerstick) blood, EDTA venous whole blood, serum and plasma samples are tested on the iStatis HBsAg Test

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. PerformanceTime frame: 3 Months
  2. Sensitivity and SpecificityTime frame: 3 Months

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • St. Vincent's Hospital, Melbourne

    Melbourne, Fitzroy Victoria, Australia

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.